dextroamphetamine has been researched along with Obesity, Morbid in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 7.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| "A limited number of published case reports suggest a positive effect of dextroamphetamine, an adrenergic agonist affecting both the central nervous system (CNS) and peripheral nervous system, on physical activity and weight in patients with hypothalamic obesity (intractable obesity following CNS insult)." | 3.91 | Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series. ( Denzer, C; Denzer, F; Lennerz, BS; Lustig, RH; Vollbach, H; Wabitsch, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denzer, C | 1 |
| Denzer, F | 1 |
| Lennerz, BS | 1 |
| Vollbach, H | 1 |
| Lustig, RH | 1 |
| Wabitsch, M | 1 |
| Welling, TH | 1 |
| Williams, DM | 1 |
| Stanley, JC | 1 |
2 other studies available for dextroamphetamine and Obesity, Morbid
| Article | Year |
|---|---|
Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.
Topics: Adolescent; Adult; Body Mass Index; Child; Cohort Studies; Dextroamphetamine; Exercise; Female; Heal | 2019 |
Excessive oral amphetamine use as a possible cause of renal and splanchnic arterial aneurysms: a report of two cases.
Topics: Administration, Oral; Adult; Aneurysm; Dextroamphetamine; Humans; Male; Middle Aged; Narcolepsy; Obe | 1998 |